|
Clinical Trials at Birmingham Gastroenterology Associates, P.C.
|
- Ulcerative Colitis studies for mild, moderate, or severe disease and those in remission.
- Crohn’s disease studies for moderate to severe flares.
- Hepatitis C studies, for patients never before treated, and those who have failed treatment or relapsed.
Trials usually consist of the standard treatment of Pegylated
interferon and ribavirin + a third investigational medication.
- Constipation, diarrhea or IBS studies
|
